Loading…
Based on limited metadata, the FDA issued a Warning Letter to Wellness BioSciences Rx on December 22, 2020, regarding drug products. Without access to the full letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata. The warning falls under FDA's drug product regulation authority, though the specific issuing office is not documented in this metadata record.